The Uterine Fibroid Market is experiencing a remarkable rise in volume, reflecting growing awareness and proactive healthcare measures. With a projected market volume reaching USD 10.41 billion by 2035, the demand for effective treatment options continues to escalate. This growth is largely attributed to the increasing prevalence of uterine fibroids, impacting a significant proportion of women...